Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-31

Clinical Trial Update: Effect of RECK in Posterior Spinal Fusion [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating RECK in posterior spinal fusion has been withdrawn, including conditions such as degenerative lumbar spinal stenosis and d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RECK (RECK)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease | Phase 1, Phase 2 | Status: WITHDRAWN